Stay updated on Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Sign up to get notified when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added a Locations section with Massachusetts sites and included Massachusetts in the site listings. Removed the HHS Vulnerability Disclosure and updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-19T10:44:38.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page shows Revision: v3.3.2, replacing Revision: v3.3.1. No study content or critical functionality is affected.
    Difference
    0.0%
    Check dated 2025-11-28T00:35:56.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1. No visible changes to study content, eligibility criteria, or locations.
    Difference
    0.0%
    Check dated 2025-11-20T23:00:55.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The government funding status notice was removed from the page. It now displays only the study details and related information.
    Difference
    0.3%
    Check dated 2025-11-13T17:06:40.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots. Any differences appear cosmetic or layout-related and do not affect core study details such as eligibility, interventions, or outcomes.
    Difference
    0.4%
    Check dated 2025-10-30T11:33:18.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    - Added: Revision: v3.2.0 update badge. - Removed: Ovarian cancer resource under Genetic and Rare Diseases Information Center topics, and removal of Revision: v3.0.2.
    Difference
    0.3%
    Check dated 2025-10-01T04:51:35.000Z thumbnail image

Stay in the know with updates to Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.